We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

High-Dose Deferoxamine in Intracerebral Hemorrhage (HI-DEF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01662895
Recruitment Status : Suspended (By DSMB due to increased incidence of ARDS. See modified protocol [NCT02175225)
First Posted : August 13, 2012
Last Update Posted : January 9, 2018
Sponsor:
Collaborators:
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018